Join our community of smart investors

Carclo has room to grow in healthcare and supercar sectors

Management is taking bold decisions in focusing on fewer specialties as it exits its second business
June 7, 2016

There's been a performance u-turn over at supercar light manufacturer Carclo (CAR), with revenues fired up in its two largest divisions. Group turnover rose nearly 11 per cent to £119m with its dominant technical plastics and LED technologies divisions most robust. The latter's Wipac luxury and supercar lighting business was singled out by management as having been a particularly strong performer, while technical plastics is approaching its medium-term target of a 10 per cent underlying operating margin.

IC TIP: Buy at 159p

The lack of a £25m impairment charge against its Conductive Inkjet Technologies (CIT) venture, which it had to stomach last year, clearly helped the reported numbers. While there was an additional impairment charge of £3m this term in respect of CIT patents and development costs, this was entirely offset by income from UniPixel, which licenses the fine line technology.

Carclo derives roughly three-fifths of its revenue from supplying injection-moulded plastic components, mainly for the medical sector. So the completion of a flagship facility in Taicang, China, for producing medical consumables, is welcome news for the company.

Management has also decided to exit its diagnostic solutions business, and so took a £4.9m impariment charge. House broker Peel Hunt marginally trimmed its adjusted pre-tax profit expectations to £10.2m for the year to March 2017, due to an additional £0.3m pension charge, giving EPS of 11.1p (from £8.8m and 10.1p FY2016).

CARCLO (CAR)
ORD PRICE:159pMARKET VALUE:£105m
TOUCH:156-159p12-MONTH HIGH:160pLOW: 105p
DIVIDEND YIELD:1.8%PE RATIO:48
NET ASSET VALUE:50p*NET DEBT:75%

Year to 31 MarTurnover (£m)Pre-tax profit (£m)Earnings per share (p)Dividend per share (p)
201293.35.57.52.40
201386.53.24.42.55
201497.34.85.52.65
2015108-24.5-33.22.75
20161193.93.32.85
% change+11--+4

Ex-div: 25 Aug

Payment: 7 Oct

*Includes intangible assets of £20m or 30.6p a share